Funds and ETFs Kangstem Biotech Co., Ltd.

Equities

A217730

KR7217730001

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
2,635 KRW -1.50% Intraday chart for Kangstem Biotech Co., Ltd. -0.94% +10.02%
Kang Stem Biotech Co., LTD is a Korea-based company mainly engaged in the development of pharmaceutical products. The Company's product portfolio consists of stem cell therapy products including Furestem-AD which used for treating atopic dermatitis, Furestem-RA which used for treating rheumatoid arthritis, Furestem-CD which used for treating crohn’s disease, stem cell conditioned medias which used as raw materials of cosmetics including umbilical cord blood-derived stem cell conditioned medias (USC-CMs) and others and stem cell culture medias including KSB-3 Complete Kit and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A217730 Stock
  4. Funds and ETFs Kangstem Biotech Co., Ltd.